TrialBritish journal of cancer2013
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.
N Colombo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papertrialcites it